2 Big Earnings Reports I'll Be Watching This Week
has put together some big revenue growth through the past few years. Since the company has so much investment capital from the Altria deal, focus will be on sales potential and how they'll work with Altria,...
5 Ways Technology Can Transform the Marijuana Industry
The traditional cannabis industry is evolving before our eyes.
Cramer's game plan: 'Get ready to ride through these troubled waters'
No summary available.
7 Marijuana Stocks to Play the CBD Trend
Cannabidiol (CBD) is emerging as a red-hot category of the marijuana industry. CBD includes compounds in the cannabis sativa plant that do not produce a high. In fact, over the years, CBDs have been shown...
Wall Street Expects These Pot Stocks to Drop by 22% to 44%
These red-hot marijuana stocks may now be too hot to handle.
Legal Marijuana Could Hurt Alcohol Stocks
The ongoing wave of cannabis legalization is good for pot companies, but the trend could be a downer for alcohol stocks, warns DataTrek.
There’s Smoke, But Is There Still Fire for ACB Stock?
Cannabis stocks are climbing this year and Aurora Cannabis (NYSE:ACB) is among the leaders of that pack. Shares of ACB stock have nearly doubled year-to-date and are in the midst of a breathtaking March...
Will Cronos Group Earnings Get an Altria Bump?
With the cigarette giant's investment in the cannabis company complete, it's up to Cronos to perform.
These Marijuana Stocks Have Doubled So Far in 2019
Find out if further gains are around the corner.
Options Traders Expect Huge Moves in Cronos (CRON) Stock
Investors need to pay close attention to Cronos (CRON) stock based on the movements in the options market lately.
Our goal is to establish the most valuable international cannabis community comprised of passionate, daring people, driven by quality and integrity, who are determined to write history, not read about it.We don’t strive to follow best practices; we aspire to set them by building industry leading companies that transform the perception of cannabis and responsibly elevate the consumer experience.We never lose sight of our consumer’s trust as a measure of our success, building an iconic portfolio that offers the most enjoyable products on the market while generating value for our shareholders.
Cronos Group Inc., formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations MMPR.
The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate. It seeks to make minority investments with appropriate governance and shareholder rights. The firm seeks board representation consistent with the size of the investment, but does not need control. Cronos Group Inc. was incorporated in January, 2013 and is based in Toronto, Canada with an additional office in Toronto, Canada.